Columbia Asset Management grew its position in shares of CVS Health Corporation (NYSE:CVS) by 1.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,498 shares of the pharmacy operator’s stock after buying an additional 101 shares during the period. Columbia Asset Management’s holdings in CVS Health Corporation were worth $683,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Jackson Grant Investment Advisers Inc. increased its position in shares of CVS Health Corporation by 0.6% in the second quarter. Jackson Grant Investment Advisers Inc. now owns 2,881 shares of the pharmacy operator’s stock worth $232,000 after purchasing an additional 18 shares during the period. Keel Point LLC increased its position in shares of CVS Health Corporation by 0.7% in the first quarter. Keel Point LLC now owns 3,296 shares of the pharmacy operator’s stock worth $259,000 after purchasing an additional 22 shares during the period. First City Capital Management Inc. increased its position in shares of CVS Health Corporation by 0.3% in the first quarter. First City Capital Management Inc. now owns 12,771 shares of the pharmacy operator’s stock worth $1,003,000 after purchasing an additional 40 shares during the period. Elefante Mark B increased its position in shares of CVS Health Corporation by 0.7% in the second quarter. Elefante Mark B now owns 6,400 shares of the pharmacy operator’s stock worth $515,000 after purchasing an additional 45 shares during the period. Finally, Traynor Capital Management Inc. increased its position in shares of CVS Health Corporation by 1.3% in the second quarter. Traynor Capital Management Inc. now owns 3,676 shares of the pharmacy operator’s stock worth $290,000 after purchasing an additional 48 shares during the period. Hedge funds and other institutional investors own 81.42% of the company’s stock.

Shares of CVS Health Corporation (NYSE CVS) opened at $71.48 on Friday. CVS Health Corporation has a 12 month low of $66.45 and a 12 month high of $84.72. The company has a market capitalization of $72,408.67, a PE ratio of 12.52, a PEG ratio of 1.23 and a beta of 0.86. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.55 and a current ratio of 1.05.

CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.01. The company had revenue of $46.18 billion for the quarter, compared to analyst estimates of $46.17 billion. CVS Health Corporation had a return on equity of 16.96% and a net margin of 2.77%. The firm’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.64 earnings per share. sell-side analysts anticipate that CVS Health Corporation will post 5.9 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 3rd. Investors of record on Tuesday, October 24th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.80%. The ex-dividend date was Monday, October 23rd. CVS Health Corporation’s dividend payout ratio is currently 41.32%.

In related news, insider Larry J. Merlo sold 241,150 shares of CVS Health Corporation stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $83.07, for a total value of $20,032,330.50. Following the transaction, the insider now directly owns 299,255 shares of the company’s stock, valued at $24,859,112.85. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Thomas M. Moriarty sold 20,547 shares of CVS Health Corporation stock in a transaction that occurred on Monday, October 2nd. The stock was sold at an average price of $81.17, for a total value of $1,667,799.99. Following the completion of the transaction, the executive vice president now directly owns 43,178 shares in the company, valued at $3,504,758.26. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 714,125 shares of company stock worth $58,119,381. 0.61% of the stock is owned by insiders.

ILLEGAL ACTIVITY NOTICE: “Columbia Asset Management Purchases 101 Shares of CVS Health Corporation (CVS)” was first published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright and trademark law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/columbia-asset-management-purchases-101-shares-of-cvs-health-corporation-cvs/1723167.html.

A number of brokerages recently commented on CVS. Loop Capital decreased their price target on CVS Health Corporation from $83.00 to $73.00 and set a “hold” rating on the stock in a research report on Tuesday, November 7th. Jefferies Group LLC decreased their price target on CVS Health Corporation from $86.00 to $76.00 and set a “hold” rating on the stock in a research report on Tuesday, November 7th. Needham & Company LLC restated a “hold” rating on shares of CVS Health Corporation in a research report on Sunday, September 10th. Oppenheimer Holdings, Inc. restated a “buy” rating and issued a $95.00 price target on shares of CVS Health Corporation in a research report on Monday, October 9th. Finally, TheStreet cut CVS Health Corporation from a “b-” rating to a “c+” rating in a research report on Tuesday, October 31st. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $85.82.

CVS Health Corporation Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.